Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U6 small nuclear 1092, pseudogene (RNU6-1092P) is a human pseudogene located on chromosome 8. It is classified as a pseudogene of the U6 small nuclear RNA (snRNA) family, which are normally involved in the spliceosome machinery for pre-mRNA splicing in eukaryotic cells. However, as a pseudogene, RNU6-1092P does not code for a functional RNA or protein product and typically does not participate directly in biological processes. Some pseudogenes may be transcribed and give rise to non-coding RNAs with potential regulatory roles, such as acting as competing endogenous RNAs (ceRNAs) or producing small interfering RNAs (siRNAs). However, there is no specific evidence that RNU6-1092P has a verified or established biological or disease-modifying role. It is not considered a therapeutic target, and there are no known drugs, mechanisms of action, or biomarker uses listed for this pseudogene.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 1092, pseudogene (RNU6-1092P).